GT
TDOC icon

Glenmede Trust’s Teladoc Health TDOC Stock Holding History

Glenmede Trust’s Portfolio TDOC Stock Details TDOC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-2,514
Closed -$318K – 1368
2021
Q3 		$318K Sell
2,514
-4
-0.2% -$582 ﹤0.01% 1016
2021
Q2 		$417K Sell
2,518
-52
-2% -$8.43K ﹤0.01% 932
2021
Q1 		$466K Sell
2,570
-724
-22% -$168K ﹤0.01% 865
2020
Q4 		$657K Buy
3,294
+944
+40% +$192K ﹤0.01% 777
2020
Q3 		$514K Sell
2,350
-63
-3% -$13.3K ﹤0.01% 778
2020
Q2 		$460K Sell
2,413
-4,306
-64% -$755K ﹤0.01% 783
2020
Q1 		$562K Hold
6,719
– – ﹤0.01% 870
2019
Q4 		$562K Buy
6,719
+108
+2% +$8.22K ﹤0.01% 870
2019
Q3 		$446K Buy
6,611
+355
+6% +$23.4K ﹤0.01% 923
2019
Q2 		$414K Sell
6,256
-3,637
-37% -$212K ﹤0.01% 953
2019
Q1 		$550K Buy
9,893
+3,545
+56% +$216K ﹤0.01% 871
2018
Q4 		$314K Sell
6,348
-351
-5% -$21.5K ﹤0.01% 971
2018
Q3 		$577K Buy
6,699
+3,802
+131% +$271K ﹤0.01% 864
2018
Q2 		$168K Buy
2,897
+1,150
+66% +$56.2K ﹤0.01% 1108
2018
Q1 		$60K Hold
1,747
– – ﹤0.01% 1563
2017
Q4 		$60K Sell
1,747
-1,334
-43% -$44.3K ﹤0.01% 1563
2017
Q3 		$101K Buy
+3,081
New +$101K ﹤0.01% 1417

Other funds holding TDOC

AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
KA
Kinnevik AB Stockholm, Sweden $65.6M AUM 25.95% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Glenmede Trust's TDOC Position: Q4 2021 in Review

Glenmede Trust sold out of Teladoc Health (TDOC) in Q4 2021, closing a stake of 2,514 shares — an estimated $318K sold.

Glenmede Trust first reported a position in TDOC in Q3 2017 and held it in 17 quarters. The position peaked at $657K in Q4 2020. 729 funds tracked by Wall St. Rank hold TDOC as of Q4 2021.

  • Glenmede Trust reported no remaining Teladoc Health position as of Q4 2021 after selling out during the quarter.
  • Glenmede Trust sold 2,514 Teladoc Health shares in Q4 2021, an estimated $318K.
  • Glenmede Trust first reported a position in Teladoc Health in Q3 2017 and held it in 17 quarters.
  • Glenmede Trust's Teladoc Health position peaked at $657K in Q4 2020.
  • 729 funds tracked by Wall St. Rank held Teladoc Health as of Q4 2021.

Based on Glenmede Trust's 13F filing for Q4 2021, filed 15 Feb 2022.